NCT02326662

Neural Stem Cell Transplantation in Traumatic Spinal Cord Injury

Safety and Efficacy of Autologous Neural Stem Cell Transplantation in Patients With Traumatic Spinal Cord Injury

• Status: Unknown
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Federal Research Clinical Center of Federal Medical & Biological Agency, Russia · Other Government
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

This research investigates the use of autologous neural stem cells in patients with complete traumatic spinal cord injury.

Detailed description

The aim of this study is to evaluate Mesenchymal Stem Cells \[MSC\]-derived autologous neural stem cells transplantation as a safe and potentially beneficial treatment for patients with traumatic spinal cord injury.

Conditions

• Spinal Cord Injury

Interventions

Type	Name	Description
BIOLOGICAL	Autologous Stem Cell Transplantation	Autologous neural stem cell transplantation Stem Cell Transplantation by intraspinal and intrathecal injection with 3D matrix as needed

Timeline

• Start date: 2014-07-01
• Primary completion: 2018-10-01
• Completion: 2018-12-01
• First posted: 2014-12-29
• Last updated: 2015-10-27

Locations

1 site across 1 country: Russia